Jianhua Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jianhua Liu has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Feng Feng
Second Hospital of Hebei Medical University, Shijiazhuang, China
1 shared publication - Jinfeng Liu
Department of Otorhinolaryngology Head and Neck Surgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China
1 shared publication - Jingjing Yuan
Department of Otorhinolaryngology—Head and Neck Surgery, Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Beijing, China
1 shared publication Liang Zhang
School of Energy and Power Engineering, University of Shanghai for Science and Technology, Shanghai, China
1 shared publicationLiangkui Qi
School of Energy and Power Engineering, University of Shanghai for Science and Technology, Shanghai, China
1 shared publication- Lili Liu
The 2nd Affiliated Hospital of Harbin Medical University
1 shared publication
Latest Publications
- 29 October 2021
- Published by Springer Nature in Heat and Mass Transfer
- Vol. 58 (5) , 873-885
Effect of environmental parameters on heat transfer characteristics and thermal sensation of human body with step change of temperature
- 29 October 2021
- Published by Springer Nature in Heat and Mass Transfer
- Vol. 58 (5) , 873-885
Effect of environmental parameters on heat transfer characteristics and thermal sensation of human body with step change of temperature
- Open Access
- 27 July 2021
- Published by Impact Journals, LLC in Aging
- Vol. 13 (14) , 18423-18441
Yiqi Jiemin decoction alleviates allergic rhinitis in a guinea pig model by suppressing inflammation, restoring Th1/Th2 balance, and improving cellular metabolism
We investigated the mechanisms underlying the therapeutic effects of Yiqi Jiemin decoction (YJD), a traditional Chinese medicine (TCM), in the ovalbumin (OVA)-induced allergic rhinitis (AR) model in guinea pigs. YJD significantly decreased infiltration of mast cells and eosinophils into the nasal mucosa of AR model guinea pigs. YJD also increased expression of TGF-β in the nasal mucosa, restored the balance of Th1/Th2 immune cell responses, and decreased serum levels of various pro-inflammatory mediators, including histamine (HA), neuropeptide Y (NPY), acetylcholine (ACH), norepinephrine and immunoglobulin E (IgE). Metabolic analyses using liquid chromatography coupled with high-resolution mass spectrometry revealed that YJD improved cellular metabolism in AR model guinea pigs and increased serum levels of glycocholic acid while decreasing levels 1-palmitoyl lysophosphatidic acid. RNA-sequencing analysis identified BPIFB2 as a potential diagnostic biomarker and therapeutic target for AR. Functional enrichment analyses showed that YJD significantly inhibited cytokine secretion pathways in AR model guinea pigs. These findings demonstrate that YJD protects against OVA-induced AR in guinea pigs by suppressing inflammation in the nasal mucosa, restoring Th1/Th2 balance, and improving cellular metabolism.
- 27 July 2021
- Published by Impact Journals, LLC in Aging
- Vol. 13 (14) , 18423-18441
Open AccessYiqi Jiemin decoction alleviates allergic rhinitis in a guinea pig model by suppressing inflammation, restoring Th1/Th2 balance, and improving cellular metabolism
We investigated the mechanisms underlying the therapeutic effects of Yiqi Jiemin decoction (YJD), a traditional Chinese medicine (TCM), in the ovalbumin (OVA)-induced allergic rhinitis (AR) model in guinea pigs. YJD significantly decreased infiltration of mast cells and eosinophils into the nasal mucosa of AR model guinea pigs. YJD also increased expression of TGF-β in the nasal mucosa, restored the balance of Th1/Th2 immune cell responses, and decreased serum levels of various pro-inflammatory mediators, including histamine (HA), neuropeptide Y (NPY), acetylcholine (ACH), norepinephrine and immunoglobulin E (IgE). Metabolic analyses using liquid chromatography coupled with high-resolution mass spectrometry revealed that YJD improved cellular metabolism in AR model guinea pigs and increased serum levels of glycocholic acid while decreasing levels 1-palmitoyl lysophosphatidic acid. RNA-sequencing analysis identified BPIFB2 as a potential diagnostic biomarker and therapeutic target for AR. Functional enrichment analyses showed that YJD significantly inhibited cytokine secretion pathways in AR model guinea pigs. These findings demonstrate that YJD protects against OVA-induced AR in guinea pigs by suppressing inflammation in the nasal mucosa, restoring Th1/Th2 balance, and improving cellular metabolism.
- Open Access
- 1 January 2020
- Published by Elsevier in Clinical Medicine
- Vol. 20 (1) , 112-113
Images of the month 2: Gastrointestinal bleeding with a large liver and a small spleen: a rare appearance of multiple myeloma
- 1 January 2020
- Published by Elsevier in Clinical Medicine
- Vol. 20 (1) , 112-113
Open AccessImages of the month 2: Gastrointestinal bleeding with a large liver and a small spleen: a rare appearance of multiple myeloma